BMRA
Biomerica IncKey Statistics
About Biomerica Inc
Biomerica Inc. (Ticker: BMRA) is an innovative biotechnology company specializing in the development and manufacturing of cutting-edge diagnostic solutions across the medical and food sectors. With a strong focus on proprietary testing methods for managing metabolic diseases, gastrointestinal disorders, and food intolerances, Biomerica is committed to improving healthcare outcomes. The company actively engages in strategic research collaborations, positioning itself to address critical unmet medical needs and harness growth opportunities in the rapidly evolving diagnostics landscape. Leveraging technological advancements and a patient-centered approach, Biomerica is well-positioned to lead transformational changes in global healthcare diagnostics.
Fundamentals
| Revenue (TTM) | $4.46M |
| Gross Profit (TTM) | 251,000 |
| EBITDA | $-5.18M |
| Operating Margin | -113.50% |
| Return on Equity | -84.30% |
| Return on Assets | -49.40% |
| Revenue/Share (TTM) | $1.70 |
| Book Value | $1.50 |
| Price-to-Book | 1.48 |
| Price-to-Sales (TTM) | 1.47 |
| EV/Revenue | 0.964 |
| EV/EBITDA | -5.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -26.00% |
| Shares Outstanding | $3.02M |
| Float | $2.70M |
| % Insiders | 15.59% |
| % Institutions | 2.96% |